Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TRINITY BIOTECH PLC

(TRIB)
  Report
Delayed Quote. Delayed Nasdaq - 11/26 12:55:00 pm
1.83 USD   +1.67%
11/15European ADRs Move Slightly Higher in Monday Trading
MT
11/02European ADRs Nudge Lower in Tuesday Trading
MT
11/01European ADRs Move Higher in Monday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Slightly Higher in Wednesday Trading

10/20/2021 | 11:06am EST


ę MT Newswires 2021
All news about TRINITY BIOTECH PLC
11/15European ADRs Move Slightly Higher in Monday Trading
MT
11/02European ADRs Nudge Lower in Tuesday Trading
MT
11/01European ADRs Move Higher in Monday Trading
MT
10/28European ADRs Gain Thursday as Anheuser-Busch InBev Jumps 10%
MT
10/21European ADRs Move Lower in Thursday Trading
MT
10/20European ADRs Move Slightly Higher in Wednesday Trading
MT
10/19European ADRs 0.6% Higher Tuesday Morning
MT
10/18European ADRs Move Lower in Monday Trading
MT
10/11European ADRs Move Higher in Monday Trading
MT
10/04European ADRs Move Lower in Monday Trading
MT
More news
Financials (USD)
Sales 2021 102 M - -
Net income 2021 12,9 M - -
Net Debt 2021 - - -
P/E ratio 2021 3,89x
Yield 2021 -
Capitalization 38,3 M 38,3 M -
Capi. / Sales 2021 0,38x
Capi. / Sales 2022 0,37x
Nbr of Employees 543
Free-Float 69,4%
Chart TRINITY BIOTECH PLC
Duration : Period :
Trinity Biotech plc Technical Analysis Chart | TRIB | US8964383066 | MarketScreener
Technical analysis trends TRINITY BIOTECH PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 1,83 $
Average target price 7,00 $
Spread / Average Target 283%
EPS Revisions
Managers and Directors
Ronan O'Caoimh Chairman & Chief Executive Officer
John Gillard CFO, Secretary & Executive Director
Eibhlin Kelly Chief Information Officer
Clinton H. Severson Lead Independent Non-Executive Director
James D. Merselis Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
TRINITY BIOTECH PLC-51.97%38
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.70.89%23 363
BIOMÉRIEUX13.04%17 469
10X GENOMICS, INC.5.12%16 628
DIASORIN S.P.A.10.11%11 598
NATERA, INC.-4.88%8 954